N-(((5S)-2-Oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-acetamide, >95% (HPLC)

cas: 1429334-00-8 — see every product listed under this CAS number, including other names

N-(((5S)-2-Oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-acetamide, >95% (HPLC) (CAS 1429334-00-8) is a chemical reagent available from Chemat. Available pack sizes: 2,5g, 250mg. Offered by: TRC.

• 2D
• 3D

N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide (CAS 1429334-00-8) is a chemical compound with the molecular formula C16H19N3O5 and a molecular weight of 333.34 g/mol. IUPAC name: N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide. InChIKey: ZINXMVCVGXRHDV-AWEZNQCLSA-N.

Identity

Molecular formula	C16H19N3O5
Molecular weight	333.34 g/mol
IUPAC name	N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide
InChIKey	ZINXMVCVGXRHDV-AWEZNQCLSA-N
SMILES	CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC=C(C=C2)N3CCOCC3=O

Computed by PubChem (NCBI)

Synonyms: N-(((5S)-2-Oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)acetamide, N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]acetamide, (S)-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)acetamide, Rivaroxaban EP Impurity B, Rivaroxaban impurity B [EP], RIVAROXABAN IMPURITY B [EP IMPURITY], (S)-N-[[2-Oxo-3-[4-(3-oxomorpholino)phenyl]-5-oxazolidinyl]methyl]acetamide, N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl]acetamide

Related forms of this compound

N-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide C₁₆H₁₉N₃O₅

Isomers (same molecular formula)

(4S)-4-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid C₁₆H₁₉N₃O₅

methyl 8-methoxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]cinnoline-6-carboxylate C₁₆H₁₉N₃O₅

(E)-2-cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide C₁₆H₁₉N₃O₅

4-(2,3,4-trimethoxyphenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid C₁₆H₁₉N₃O₅

(2R)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid C₁₆H₁₉N₃O₅

(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]pentanedioic acid C₁₆H₁₉N₃O₅

(2S)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid C₁₆H₁₉N₃O₅

(4S)-4-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid C₁₆H₁₉N₃O₅

methyl 2-[6-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxoquinazolin-3-yl]acetate C₁₆H₁₉N₃O₅

3-[(E)-[5-(morpholin-4-ylmethyl)-2-oxo-1,3-oxazolidin-3-yl]iminomethyl]benzoic acid C₁₆H₁₉N₃O₅

N-[[(5S)-3-[1-(2-hydroxyacetyl)-2,3-dihydroindol-5-yl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide C₁₆H₁₉N₃O₅